HOWL Q1 2025 Earnings — Werewolf Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HOWLWerewolf Therapeutics, Inc.

$35M

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$426,000

Operating Income

-$18M

Net Income

-$18M

EPS (Diluted)

$-0.40

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$19M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$107M

Total Liabilities

$50M

Stockholders' Equity

$57M

Cash & Equivalents

$92M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$742,000	-100.0%
Gross Profit	-$426,000	$278,000	-253.2%
Operating Income	-$18M	-$17M	-4.8%
Net Income	-$18M	-$16M	-11.7%